FDA approves Opus Genetics’ phentolamine eye drops for presbyopia
The FDA approved phentolamine ophthalmic solution 0.75% for the treatment of presbyopia.
Story updates
04:01:32 PM UTC
SquawkNews
Opus Genetics received FDA approval of its sNDA for phentolamine ophthalmic solution 0.75% (RYZUMVI) to treat presbyopia in adults, triggering a milestone payment under its U.S. commercialization deal with Viatris.Material DetailsContext by AI AnalystThis is a label expansion from an already market…